Our offices are now closed. If you have a life-threatening emergency or urgent clinical need, please hang up and dial 911 or go to your nearest emergency department. For non-urgent issues, please click here for our After-Hours Frequently Asked Questions. If you need to request a prescription refill, please contact your pharmacy directly. You may also call us at 704-372-7900 to leave a general voice message or reach our after-hours answering service.
Our New NextGen Patient Portal is live. Please refer to the email. -------------- Kindly remember masks are still required.
For Detailed Pollen Info, Click Here

Pollen and Mold Levels

The Carolina Asthma & Allergy Center Pollen and Mold Counter will return February 15, 2022.

View Detailed Pollen Info

FDA Issues Drug Safety Communication for Singulair (Montelukast)

Posted on: March 16, 2020

85239 FDA Issues Drug Safety Communication for Singulair (Montelukast)The safety of our patients is very important to us. We want to make you aware that the Food and Drug Administration (FDA) has issued a drug safety communication for Singulair (Montelukast) concerning the risk neuropsychiatric events. Singulair is commonly used to prevent asthma attacks and allergy symptoms.

Please contact our office at 704.372.7900 if you are using Singulair and experience any mood changes.

For more information on this communications, visit the FDA website.

Categories

Contact Us